Navigation Links
Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs
Date:3/8/2011

core portfolio include a vaccine against hepatitis B and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as an oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market. Crucell has a broad development pipeline, with several product candidates based on its unique PER.C6® production technology. Crucell licenses its PER.C6® technology and other technologies to the biopharmaceutical industry. Important partners and licensees include Johnson & Johnson, DSM Biologics, sanofi-aventis, Novartis, Pfizer/Wyeth, GSK, CSL and Merck & Co. Crucell is headquartered in Leiden, the Netherlands, with offices in China, Indonesia, Italy, Korea, Malaysia, Spain, Sweden, Switzerland, UK, the USA and Vietnam. Crucell employs over 1300 people. For more information, please visit www.crucell.com.

About Johnson & JohnsonCaring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day throughout the world.

Forward-looking statements(This press release contains "forward-looking statements". All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's and Crucell's expectations and projections. Risks and uncertainties include general industry conditions and competition; general domestic and intern
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
4. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
5. Johnson & Johnson Receives Approval from European Commission
6. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
7. Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
8. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
9. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
10. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
11. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... Council today recognized world-class manufacturing companies and ... Manufacturing Leadership Awards. Logo - ... world of intensifying global competition and accelerating, ... have distinguished themselves by embracing breakthrough innovation ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... the "Telemedicine and Mobile Healthcare Solutions, Services, ... 2020" report to their offering. ... all terms that pertain to the use of ... remote clinical/non-clinical healthcare services. They form the ecosystem ...
(Date:3/3/2015)... Israel , March 3, 2015 /PRNewswire/ ... the "Company"), an Israeli biopharmaceutical company primarily ... for inflammatory and gastrointestinal diseases, including gastrointestinal ... , RedHill,s Chief Business Officer, will be ... online event, on Thursday, March 5, 2015, ...
Breaking Medicine Technology:2015 Manufacturing Leadership Award Winners Announced 22015 Manufacturing Leadership Award Winners Announced 32015 Manufacturing Leadership Award Winners Announced 42015 Manufacturing Leadership Award Winners Announced 52015 Manufacturing Leadership Award Winners Announced 6Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 2Global Telemedicine and Mobile Healthcare Solutions, Services, and Devices: Market Analysis and Forecasts 2015 - 2020 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 4
... Pa., Aug. 17, 2011 Endo Pharmaceuticals (Nasdaq: ... program and collaboration related to the development of axomadol. Endo ... United States and Canada from Grunenthal in February 2009. ... management, Endo remains committed to the development and commercialization of ...
... IRVINE, Calif., Aug. 17, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today that Judge Tanya Walton Pratt ... of Indiana in Indianapolis has issued a Markman ruling in ... Cook Medical. In a Markman ruling, the ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Endologix Announces Favorable Markman Ruling in Cook Patent Litigation 2
(Date:3/4/2015)... Jose, CA (PRWEB) March 04, 2015 ... produced by companies whose management forgot – or ignored ... potential value: Validate the market based on physician input ... seen companies – more specifically, founders – become so ... answer the key question: Will physicians use the device?” ...
(Date:3/3/2015)... MA (PRWEB) March 04, 2015 ... educational facilities design and construction event for New ... Boston Massachusetts announced key building envelope related workshops. ... , Workshops include: , Curtain Walls ... in many health care and laboratory facilities are ...
(Date:3/3/2015)... Anik Singal's Profit Academy ... ambitious online marketers has become the talk of ... media attention surrounding the course's general release has ... Hendricks, prompting her to review the program's content ... of the biggest keys to success with Internet ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 NOVAtime ... of enterprise Time and Attendance / Workforce Management ... to NOVAtime SaaS Workforce Management / Time ... and attendance processes. , Since 2004, Innovative ... developmental disabilities with the best quality of life. ...
(Date:3/3/2015)... Hollywood, California (PRWEB) March 03, 2015 ... was transformed into the fabulous EcoLuxe Lounge, a day-long ... sustainable and socially conscious products and services. Organized by ... product TV and film placement producer, the EcoLuxe Lounge ... the star of roles on General Hospital, The Flash, ...
Breaking Medicine News(10 mins):Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2
... Dec. 1 (HealthDay News) -- The genetic repair of cleft ... to treat and prevent the birth defect in humans, U.S. ... for specific proteins that coordinate cellular signaling behaviors that play ... palate. Working with specially engineered mice, they also reported that ...
... Dec. 1 (HealthDay News) -- Posting information about inspections and ... Internet so it can be viewed by the public could ... The report is from the National Research Council (NRC), a ... the United States and the world. According to the ...
... have discovered that over a million people worldwide diagnosed with ... infection which is usually left untreated because it is mistaken ... report published today in the Bulletin of the World ... University of Toronto say because the X-ray features and symptoms ...
... [Geneva/New York, 1 December 2011] Less than one-quarter ... getting it, according to a report released by the ... AIDS Day (1 December 2011). Although treatment coverage for ... approximately half of those in need, coverage for children ...
... Only 21 percent of surveyed medical students could identify five ... to wash their hands in the clinical setting, according to ... American Journal of Infection Control , the official publication of ... Epidemiology. Three researchers from the Institute for Medical ...
... , WEDNESDAY, Nov. 30 (HealthDay News) -- People taking the ... their dosage can reduce the risk of blood clots by ... to prevent potentially deadly clots in patients with conditions such ... a mechanical heart valve. But if the blood is thinned ...
Cached Medicine News:Health News:Mistaken identity: New report highlights the global impact of medical misdiagnosis 2Health News:Children with HIV/AIDS falling through the cracks of treatment scale-up efforts 2Health News:2 out of 3 medical students do not know when to wash their hands 2Health News:Self-Monitoring of Blood Thinner May Halve Clot Risk 2Health News:Self-Monitoring of Blood Thinner May Halve Clot Risk 3
The Auto Suture&trade ENDO RETRACT&trade Maxi instrument has application in a variety of general, thoracic, gynecologic, urologic, and endoscopic procedures for temporary retracting of tissue and sma...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: